 |
 |
we have just been offered more openings in our ongoing entacapone study. Entacappone is a COMT inhibitor which is effective as an adjunct to sinemet to help control motor fluctuations. Patints who do not have too much dyskinesia are best for this trial. If you live live near Los Angeles and are interested in being considered for this study ,call Mickie at 213-342-5814.